Share-based Payment Arrangement, Expense of bluebird bio, Inc. from 31 Dec 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
bluebird bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2012 to 31 Mar 2025.
  • bluebird bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $1,660,000, a 56% decline year-over-year.
  • bluebird bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2025 was $11,635,000, a 35% decline year-over-year.
  • bluebird bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $13,736,000, a 29% decline from 2023.
  • bluebird bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19,429,000, a 45% decline from 2022.
  • bluebird bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $35,090,000, a 64% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

bluebird bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $11,635,000 $1,660,000 -$2,101,000 -56% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $13,736,000 $4,068,000 +$652,000 +19% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $13,084,000 $2,701,000 -$2,167,000 -45% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $15,251,000 $3,206,000 -$2,548,000 -44% 01 Apr 2024 30 Jun 2024 10-Q 27 Sep 2024 2024 Q2
Q1 2024 $17,799,000 $3,761,000 -$1,630,000 -30% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $19,429,000 $3,416,000 -$1,165,000 -25% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $20,594,000 $4,868,000 -$4,344,000 -47% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $24,938,000 $5,754,000 -$3,153,000 -35% 01 Apr 2023 30 Jun 2023 10-Q 27 Sep 2024 2024 Q2
Q1 2023 $28,091,000 $5,391,000 -$6,999,000 -56% 01 Jan 2023 31 Mar 2023 10-Q 13 Sep 2024 2024 Q1
Q4 2022 $35,090,000 $4,581,000 -$18,485,000 -80% 01 Oct 2022 31 Dec 2022 10-K 13 Sep 2024 2023 FY
Q3 2022 $53,575,000 $9,212,000 -$12,042,000 -57% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $65,617,000 $8,907,000 -$14,219,000 -61% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $79,836,000 $12,390,000 -$18,904,000 -60% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $98,740,000 $23,066,000 +$24,110,000 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $74,630,000 $21,254,000 -$17,564,000 -45% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $92,194,000 $23,126,000 -$25,403,000 -52% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $117,597,000 $31,294,000 -$4,999,000 -14% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $122,596,000 $1,044,000 -$6,129,000 -121% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2023 2022 FY
Q3 2020 $128,725,000 $38,818,000 +$272,000 +0.71% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $128,453,000 $48,529,000 -$6,582,000 -12% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $135,035,000 $36,293,000 +$3,952,000 +12% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $131,083,000 $5,085,000 -$24,903,000 -83% 01 Oct 2019 31 Dec 2019 10-K 04 Mar 2022 2021 FY
Q3 2019 $155,986,000 $38,546,000 +$8,749,000 +29% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020 2020 Q3
Q2 2019 $147,237,000 $55,111,000 +$27,055,000 +96% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $120,182,000 $32,341,000 +$9,346,000 +41% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $110,836,000 $29,988,000 +$15,659,000 +109% 01 Oct 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
Q3 2018 $95,177,000 $29,797,000 +$15,814,000 +113% 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3
Q2 2018 $79,363,000 $28,056,000 +$14,567,000 +108% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $64,796,000 $22,995,000 +$11,514,000 +100% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q4 2017 $53,282,000 $14,329,000 +$5,403,000 +61% 01 Oct 2017 31 Dec 2017 10-K 18 Feb 2020 2019 FY
Q3 2017 $47,879,000 $13,983,000 +$4,078,000 +41% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018 2018 Q3
Q2 2017 $43,801,000 $13,489,000 +$2,707,000 +25% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $41,094,000 $11,481,000 +$1,338,000 +13% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q4 2016 $39,756,000 $8,926,000 -$1,183,000 -12% 01 Oct 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
Q3 2016 $40,939,000 $9,905,000 +$376,000 +3.9% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017 2017 Q3
Q2 2016 $40,563,000 $10,782,000 -$5,268,000 -33% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017 2017 Q2
Q1 2016 $45,831,000 $10,143,000 +$4,711,000 +87% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q4 2015 $41,120,000 $10,109,000 +$7,104,000 +236% 01 Oct 2015 31 Dec 2015 10-K 21 Feb 2018 2017 FY
Q3 2015 $34,016,000 $9,529,000 +$6,615,000 +227% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016 2016 Q3
Q2 2015 $27,401,000 $16,050,000 +$13,699,000 +583% 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016 2016 Q2
Q1 2015 $13,702,000 $5,432,000 +$2,939,000 +118% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q4 2014 $10,763,000 $3,005,000 01 Oct 2014 31 Dec 2014 10-K 22 Feb 2017 2016 FY
Q3 2014 $2,914,000 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $2,351,000 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $2,493,000 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1

bluebird bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $13,736,000 -$5,693,000 -29% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $19,429,000 -$15,661,000 -45% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $35,090,000 -$63,650,000 -64% 01 Jan 2022 31 Dec 2022 10-K 13 Sep 2024 2023 FY
2021 $98,740,000 -$23,856,000 -19% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $122,596,000 -$8,487,000 -6.5% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2023 2022 FY
2019 $131,083,000 +$20,247,000 +18% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2022 2021 FY
2018 $110,836,000 +$57,554,000 +108% 01 Jan 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
2017 $53,282,000 +$13,526,000 +34% 01 Jan 2017 31 Dec 2017 10-K 18 Feb 2020 2019 FY
2016 $39,756,000 -$1,364,000 -3.3% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
2015 $41,120,000 +$30,357,000 +282% 01 Jan 2015 31 Dec 2015 10-K 21 Feb 2018 2017 FY
2014 $10,763,000 +$4,272,000 +66% 01 Jan 2014 31 Dec 2014 10-K 22 Feb 2017 2016 FY
2013 $6,491,000 +$5,669,000 +690% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $822,000 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.